Cargando…
379. Epidemiology of Antimicrobial Use Among SARS-CoV-2 Positive and Negative Admissions in the US: A Multicenter Evaluation
BACKGROUND: SARS-CoV-2, a novel coronavirus, emerged in Wuhan, China in December of 2019, and became a pandemic. Increases in bacterial/fungal co-infections have occurred during influenza pandemics and early data from this pandemic indicate high utilization of antimicrobial therapy. We compared the...
Autores principales: | Puzniak, Laura A, Bauer, Karri A, Finelli, Lyn, De Anda, Carisa, Moise, Pamela, Yu, Kalvin, Vankeepuram, Latha, Parikh, Prashant, Gupta, Vikas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777122/ http://dx.doi.org/10.1093/ofid/ofaa439.574 |
Ejemplares similares
-
A multicenter analysis of the clinical microbiology and antimicrobial usage in hospitalized patients in the US with or without COVID-19
por: Puzniak, Laura, et al.
Publicado: (2021) -
373. Comparison of the Epidemiology and Pathogens Cultured from Patients Hospitalized with SARS-CoV-2 Positive versus SARS-CoV-2 Negative in the US: A Multicenter Evaluation
por: Puzniak, Laura A, et al.
Publicado: (2020) -
Effect of Inadequate Empiric Antibacterial Therapy on Hospital Outcomes in SARS-CoV-2-Positive and -Negative US Patients With a Positive Bacterial Culture: A Multicenter Evaluation From March to November 2020
por: Puzniak, Laura, et al.
Publicado: (2021) -
Association of SARS-CoV-2 status and antibiotic-resistant bacteria with inadequate empiric therapy in hospitalized patients: a US multicenter cohort evaluation (July 2019 - October 2021)
por: Bauer, Karri A., et al.
Publicado: (2023) -
A Multicenter Comparison of Prevalence and Predictors of Antimicrobial Resistance in Hospitalized Patients Before and During the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic
por: Bauer, Karri A, et al.
Publicado: (2022)